供应商 · 生产商 · 发现——同类成熟企业

MustGrow Biologics Corp

在合成产品面临日益严格的审视、重重限制和逐步淘汰的时代，MustGrow 为这一日益严重的问题提供全天然方案：合成产品对种植者越来越不友好、越来越难获得，而 MustGrow 的技术有效、安全且易用。消费者对有机农产品的需求持续攀升，但与常规种植不同，有机生产中防治线虫的选项依然有限——MustGrow 的肥料产品已列入 OMRI 有机生产名录，生物农药产品亦符合 OMRI 使用资格。其技术的线虫防治效果与合成替代品相当且常常更优，带来更高的产量和收益：迄今已完成 110 多项独立第三方田间试验，并与领先种植者合作，持续提供一流表现。我们志在增值并应对全球线虫问题——改变格局的技术提供创新的作物保护：这些新型植物化合物由自然设计、经我们精炼。

运营中加拿大美国与加拿大成立 2018 核实于 2026-10-05

简介

行业: 生物炼制, 植物保护, 肥料与植物营养, 工业化学, 采后处理与加工
主题: 植保化学品与肥料, 生物农药与生物防治, 生物肥料与生物刺激素
角色: 生产商 — “…under USDA NOP listings for Plant Extracts and related classes. - Soil Biocontrol: A platform for treating soi…”
为何属于生物经济: MustGrow Biologics Corp.是一家农业生物技术公司，开发并商业化源自芥末的天然生物解决方案，用于土壤健康、生物防治和生物肥力，以替代合成化学品。
发现途径: Vestaron; Terramera; [Rubric] Canada · biocontrol; [Rubric] Canada · inoculants

供应的生物解决方案 0

尚未被列为已评级方案的供应商。

产品与服务

该公司未公开其产品或服务——我们可通过引荐了解。

新闻与状态 6

2026-04 最新状态: 公司于2026年4月15日关闭其全资加拿大营销与分销业务 NexusBioAg。 ↗ ↗ ↗
2026-08-21 MustGrow Receives First Milestone Payment from Bayer AG - MustGrow
MustGrow Biologics Corp. has received its first milestone payment from Bayer under their December 2023 license agreement, validating the partnership and the potential of MustGrow’s TerraMG biocontrol technology for Europe, the Middle East, and Africa. The deal …
2026-08-24 First Bayer milestone payment received for mustard-based biocontrol – BNN Bloomberg
MustGrow Biologics Corp. is advancing a mustard-seed–derived biocontrol technology (TerraMG) to replace synthetic soil fumigants, licensing it to Bayer for Europe, the Middle East, and Africa, with Bayer handling regulatory and commercialization in that …
2026-08-27 2026-08-27 | MustGrow Announces Second Quarter 2026 Financial Results | TSXV:MGRO | Press Release
MustGrow Biologics Corp. reports a transitional Q2-2026 with positive continuing operations (net profit from continuing ops of $0.4M) driven by a $1.4M licensing milestone, offset by lower TerraSante sales due to ramping contract manufacturing; YTD TerraSante …
2026-05-25 MustGrow Receives Texas, Utah, and Montana Registrations for TerraSanteᵀᴹ Biofertility Product - MustGrow
MustGrow Biologics Corp. announces that TerraSante, its mustard-derived organic biofertility product, has been registered for sale in Texas, Utah, and Montana, adding to certifications in several states and California, with data suggesting it can improve soil …
2026-09-04 MustGrow targets $380B agriculture market with field-proven, mustard-based biologicals – BNN Bloomberg
MustGrow Biologics Corp. develops agricultural biotech products from natural compounds found in mustard seed to help farmers boost yields, and manage diseases and nematodes, aiming to reduce input use and produce more food. The company is Saskatoon-based and …
2026-08-27 MustGrow Announces Second Quarter 2026 Financial Results | INN
MustGrow Biologics Corp. reports a transition period in Q2 2026 with $1.4 million in licensing revenue, continued operating expenses of about $0.9 million, and a Q2 net continuing-operations profit of $0.4 million, while TerraSante sales faced supply-chain …

关系网络：股东、合作伙伴、同类

股权与投资方 1

母公司	Independent

合作与交易 4

交易对手	Bayer AG …The company closed its wholly-owned Canadian marketing and distribution business, NexusBioAg, effective April 15, 2026.…
许可	MustGrow maintains a commercial licensing agreement …opesticide currently undergoing regulatory review. MustGrow maintains a commercial licensing agreement with Bayer AG for biocontrol technologies in Europe, the Middle East, and Africa.…
许可	Europe …control technologies in Europe, the Middle East, and Africa, marking its first commercial licensing agreement. - Positioned as a … - — MustGrow is a biotech company specializing in mustard-seed…
许可	Europe …chnologies in Europe, the Middle East, and Africa (signed December 2023; first commercial licensing agreement). - Strategic emphasis on exclusive R&D partnerships outside North America, followed by…

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录